论文部分内容阅读
目的:探讨经BAI(选择性支气管动脉灌注化疗)对肺癌综合治疗的缓解率及生存率。方法:采用选择性支气管动脉灌注方法治疗102例中晚期肺癌病人,随访期间为2个月~3年。结果:全组治疗后的总缓解率为80.09%,平均缓解期23.69周。治疗后的1、2、3年生存率分别为71%、42%、28.6%,平均生存期1.53年。结论:单因素和多因素分析结果表明病理分型和治疗次数可能是影响疗效的独立因素
Objective: To investigate the remission rate and survival rate of comprehensive treatment for lung cancer with BAI (selective bronchial arterial infusion chemotherapy). Methods: 102 patients with advanced lung cancer were treated with selective bronchial arterial infusion. The follow-up period was 2 months to 3 years. Results: The total remission rate after treatment in the whole group was 80.09%, and the average remission period was 23.69 weeks. The 1-, 2-, and 3-year survival rates after treatment were 71%, 42%, and 28.6%, respectively, and the average survival time was 1.53 years. Conclusion: The results of univariate and multivariate analysis indicate that pathological type and number of treatments may be independent factors influencing efficacy